Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Current Assets (2020 - 2025)

DocGo has reported Current Assets over the past 6 years, most recently at $152.4 million for Q4 2025.

  • Quarterly results put Current Assets at $152.4 million for Q4 2025, down 49.95% from a year ago — trailing twelve months through Dec 2025 was $152.4 million (down 49.95% YoY), and the annual figure for FY2025 was $152.4 million, down 49.95%.
  • Current Assets for Q4 2025 was $152.4 million at DocGo, down from $190.2 million in the prior quarter.
  • Over the last five years, Current Assets for DCGO hit a ceiling of $338.9 million in Q4 2023 and a floor of $220081.0 in Q3 2021.
  • Median Current Assets over the past 5 years was $262.5 million (2025), compared with a mean of $226.5 million.
  • Biggest five-year swings in Current Assets: surged 114400.04% in 2022 and later tumbled 49.95% in 2025.
  • DocGo's Current Assets stood at $256.0 million in 2021, then increased by 5.88% to $271.1 million in 2022, then increased by 25.01% to $338.9 million in 2023, then fell by 10.15% to $304.5 million in 2024, then tumbled by 49.95% to $152.4 million in 2025.
  • The last three reported values for Current Assets were $152.4 million (Q4 2025), $190.2 million (Q3 2025), and $236.6 million (Q2 2025) per Business Quant data.